Incorporation and distribution of uranium in rats after a contamination on intact or wounded skin

Health Physics

Volumn 92, Issue 5, 2007, Pages 464-474

  Petitot, F ^a   Frelon, S ^b   Moreels, A M ^b   Claraz, M ^b   Delissen, O ^b   Tourlonias, E ^b   Dhieux, B ^b   Maubert, C ^b   Paquet, F ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b NONE

Author keywords

Biokinetics; Rat; Skin dose; Uranium

Indexed keywords

NITRIC ACID; SODIUM HYDROXIDE; URANIUM; URANYL NITRATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; DISEASE COURSE; DRUG ABSORPTION; DRUG EXCRETION; DRUG UPTAKE; EXPOSURE; IN VIVO STUDY; KINETICS; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; RISK; SKIN INJURY; WOUND INFECTION;

ANIMALS; FECES; MALE; METABOLIC CLEARANCE RATE; OCCUPATIONAL EXPOSURE; ORGAN SPECIFICITY; RATS; SKIN; SKIN ABSORPTION; TISSUE DISTRIBUTION; URANIUM; WOUNDS AND INJURIES;

RATTUS;

EID: 34247105882     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HP.0000255659.86606.97     Document Type: Article

References (28)

1. Baglan N, Cossonnet C, Trompier F, Ritt J, Berard P. Implementation of ICP-MS protocols for uranium urinary measurements in worker monitoring. Health Phys 77:455-461; 1999.
2. Ballou JE, Gies RA, Case AC, Haggard DL, Buschbom RL, Ryan JL. Deposition and early disposition of inhaled 233UO2(NO3)2 and 232UO2(NO3)2 in the rat. Health Phys 51:755-771; 1986.
3. Berard P, Quesne B, Auriol B, Chalabreysse J. Cutaneous contamination after a uranyl nitrate skin burn: incident report. Radiat Protect Dosim 53:269-272; 1994.
4. de Rey BM, Lanfranchi HE, Cabrini RL. Percutaneous absorption of uranium compounds. Environ Res 30:480-491; 1983.
5. Diamond GL, Morrow PE, Panner BJ, Gelein RM, Baggs RB. Reversible uranyl fluoride nephrotoxicity in the Long Evans rat. Fundam Appl Toxicol 13:65-78; 1989.
6. Ejnik JW, Hamilton MM, Adams PR, Carmichael AJ. Optimal sample preparation conditions for the determination of uranium in biological samples by kinetic phosphorescence analysis (KPA). J Pharm Biomed Anal 24:227-235; 2000.
7. Frelon S, Houpert P, Lepetit D, Paquet F. The chemical speciation of uranium in water does not influence its absorption from the gastrointestinal tract of rats. Chem Res Toxicol 18:1150-1154; 2005.
8. Guglielmotti MB, Ubios AM, de Rey BM, Cabrini RL. Effects of acute intoxication with uranyl nitrate on bone formation. Experientia 40:474-476; 1984.
9. Guilmette RA, Hahn FF, Durbin PW. Biokinetics and dosimetry of depleted uranium (DU) in rats implanted with DU fragments. In: Proceedings of the 9th International Conference on Health Effects of Incorporated Radionuclides - Emphasis on Radium, Thorium, Uranium and their Daughter Product. Neuherberg: GSF-Forschungszentrum; 2005:174-178.
10. Hahn FF, Guilmette RA, Hoover MD. Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats. Environ Health Perspect 110:51-59; 2002.
11. Harrison JD, Stather JW. The gastrointestinal absorption of protactinium, uranium, and neptunium in the hamster. Radiat Res 88:47-55; 1981.
12. Hedaya MA, Birkenfeld HP, Kathren RL. A sensitive method for the determination of uranium in biological samples utilizing kinetic phosphorescence analysis (KPA). J Pharm Biomed Anal 15:1157-1165; 1997.
13. Hodge H, Stannard J, Hursh J. Uranium-plutonium, transplutonic elements. Handbook Experimental Pharmacol 36:241-270; 1973.
14. Houpert P, Chazel V, Paquet F, Bailly T, Burgada R, Henge-Napoli MH. Reduction of uranium transfer by local chelation in simulated wounds in rats. Hum Exp Toxicol 20:237-241; 2001.
15. International Commission on Radiological Protection. The metabolism of plutonium and related elements. Oxford: Elsevier; ICRP Publication 48, Annals of the ICRP 16; 1986.
16. International Commission on Radiological Protection. Age-dependent doses to members of the public from intake of radionuclides, Part 3. Ingestion dose coefficients. Oxford: Elsevier; ICRP Publication 69; 1995.
17. International Commission on Radiological Protection. Individual monitoring for internal exposure of workers. Oxford: Elsevier; ICRP Publication 78, Annals of the ICRP 27:1; 1998.
18. La Touche YD, Willis DL, Dawydiak OI. Absorption and biokinetics of U in rats following an oral administration of uranyl nitrate solution. Health Phys 53:147-162; 1987.
19. Leggett RW. The behavior and chemical toxicity of U in the kidney: a reassessment. Health Phys 57:365-383; 1989.
20. Leggett RW. Basis for the ICRP's age-specific biokinetic model for uranium. Health Phys 67:589-610; 1994.
21. Lopez R, Diaz Sylvester PL, Ubios AM, Cabrini RL. Percutaneous toxicity of uranyl nitrate: its effect in terms of exposure area and time. Health Phys 78:434-437; 2000.
22. Morrow P, Gelein R, Beiter H, Scott J, Picano J, Yuile C. Inhalation and intravenous studies of UF6/UO2F2 in dogs. Health Phys 43:859-873; 1982.
23. Neuman WF, Fleming RW, Dounce AL, Carlson AB, O'Leary J, Mulryan B. The distribution and excretion of injected uranium. J Biol Chem 173:737-748; 1948.
24. Pellmar TC, Fuciarelli AF, Ejnik JW, Hamilton M, Hogan J, Strocko S, Emond C, Mottaz HM, Landauer MR. Distribution of uranium in rats implanted with depleted uranium pellets. Toxicol Sci 49:29-39; 1999.
25. Petitot F, Moreels AM, Paquet F. In vitro evaluation of percutaneous diffusion of uranyl nitrate through intact or excoriated skin of rat and pig. Can J Physiol Pharmacol 82:133-139; 2004.
26. Tymen H, Gerasimo P, Hoffschir D. Contamination and decontamination of rat and human skin with plutonium and uranium, studied with a Franz's chamber. Int J Radiat Biol 76:1417-1424; 2000.
27. Voegtlin C, Hodge HC. Pharmacology and toxicology of uranium compounds. New York: McGraw Hill; 1949.
28. Walinder G. Metabolism and sites of effects of uranium after incorporation along different routes in mice, rabbits and piglets. Radiat Protect Dosim 26:89-95; 1989.